TB-500 10mg

Product Overview

TB-500 10mg is a synthetic peptide analogue derived from a naturally occurring protein known as thymosin beta-4. The peptide consists of a short amino acid fragment designed for stability during peptide research investigations.

Peptides are short chains of amino acids that function as signaling molecules within biological systems. Researchers frequently examine peptide analogues in laboratory environments to better understand cellular signaling pathways, molecular communication processes, and peptide interaction dynamics.

TB-500 10mg has become a molecule of interest in peptide research due to its structural characteristics and stability during controlled experimental investigation.

Chemical Information

Peptide Name: TB-500 10mg
Quantity: 10mg
Sequence Length: 17 amino acids
Molecular Formula: C₂₁₂H₃₅₀N₅₆O₇₈S
Molecular Weight: ~1944.2 g/mol
Purity: ≥99%
Appearance: Lyophilized white powder

Analytical Verification

Each batch of TB-500 10mg undergoes analytical verification to confirm compound identity and purity. Analytical procedures commonly include high-performance liquid chromatography (HPLC) and additional analytical techniques used to evaluate peptide composition and structural integrity.

Verification procedures evaluate:

• peptide purity profile
• chromatographic retention time
• batch consistency
• molecular identity confirmation

Analytical data corresponding to each batch is documented through a Certificate of Analysis (COA).

Certificate of Analysis

A Certificate of Analysis provides documentation associated with a specific production lot. These documents typically contain analytical data confirming compound purity and laboratory testing methodology.

COA documentation commonly includes:

• batch identification number
• purity percentage
• chromatographic testing results
• analytical method
• laboratory verification data

Researchers reference COA documentation to maintain traceability and consistency within experimental workflows.

Peptide Synthesis

TB-500 is 10mg produced using solid-phase peptide synthesis (SPPS), a process widely used for assembling peptide sequences through sequential amino acid coupling.

The synthesis process typically includes:

1. sequential amino acid assembly

2. purification using chromatographic separation

3. analytical confirmation of molecular identity

4. lyophilization to maintain compound stability

Following purification, the compound is freeze-dried to preserve structural integrity during storage and transportation.

Storage Conditions

Lyophilized peptides should be stored under controlled conditions to maintain stability.

Recommended handling considerations include:

• storing in a cool dry environment
• minimizing exposure to moisture and heat
• avoiding repeated freeze-thaw cycles after reconstitution

Proper storage helps maintain compound integrity during laboratory research.

Available Sizes

TB-500 – 10mg

Each vial is labeled with batch identification to support traceability for laboratory research applications.

Related Peptide Compounds

Researchers investigating peptide signaling pathways often examine related peptide compounds including:

BPC-157 – 5mg
BPC-157 – 10mg
BPC-157 + TB-500 – 5mg + 5mg

These peptides are commonly studied together in laboratory research environments investigating peptide interaction and molecular signaling processes.

References

Scientific literature describing peptide signaling mechanisms and experimental peptide research is available through peer-reviewed research databases.

PubMed

Disclaimer

This product is supplied for laboratory research use only.
Not intended for human or veterinary use.

Products distributed by Aevitas Research are intended exclusively for laboratory research purposes and must be handled by qualified professionals in controlled research environments.